Cas:1201-99-6 Trans-2,4-Dichlorocinnamic Acid manufacturer & supplier

Chemical Name:Trans-2,4-Dichlorocinnamic Acid

CAS.NO:1201-99-6

Synonyms:MFCD00004373;2-Propenoic acid, 3-(2,4-dichlorophenyl)-, (2E)-;EINECS 214-860-1;2,4-Dichlorocinnamic acid;(2E)-3-(2,4-Dichlorophenyl)acrylic acid;trans-2,4-Dichlorocinnamicacid

Molecular Formula:C₉H₆Cl₂O₂

Molecular Weight:217.049

HS Code:

Physical and Chemical Properties:

Melting point:233-237ºC

Boiling point:359.4±27.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.638

PSA:37.30000

Exact Mass:215.974487

LogP:3.33

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD00004373 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-2,4-Dichlorocinnamicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-Dichlorocinnamic acid Use and application,2-Propenoic acid, 3-(2,4-dichlorophenyl)-, (2E)- technical grade,usp/ep/jp grade.

Related News: The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. Trans-2,4-Dichlorocinnamic Acid manufacturer DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. Trans-2,4-Dichlorocinnamic Acid supplier DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. Trans-2,4-Dichlorocinnamic Acid vendor Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. Trans-2,4-Dichlorocinnamic Acid factory In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.